Li Jingliang has notified of a potential USADA violation for his out-of-competition drug test, the UFC revealed in a statement.
Jingliang was tested prior to competing on The Ultimate Fighter Finale event in July, with the results just not being released. He earned a first round finish over Anton Zafir.
Here is the full statement from the UFC:
“The UFC organization was notified by the U.S. Anti-Doping Agency (USADA) that it has informed Li Jingliang of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on May 18, 2016. USADA also informed the UFC that it initiated an investigation into the source of the prohibited substance detected in Jingliang’s sample prior to notifying him of the potential violation. Because of this investigation, USADA has not issued a provisional suspension against Jingliang at this time.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, a full and fair legal review process is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission has also retained jurisdiction over this matter because Jingliang’s sample was collected prior to his participation on The Ultimate Fighter Finale card on July 8, 2016, in Las Vegas, Nevada.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”